Cohort – I having previously cautioned on its outlook, profit warning...
Previously writing on technology company to defence and related markets Cohort (CHRT), in September with the shares lower to 568p I concluded including also noted is that some delays have persisted – with the company noting some extended negotiations, restrictions impact and supply chain challenges… at this juncture, just on the watchlist. The shares last closed at 600p, but are currently lower towards 500p on the back of half-year results. So what’s the story now?...

